Home
Search
94 Results Found

Gavel sitting on top of a book that reads PATENT LAW
BIO Urges USTR To Take Action on Growing IP Barriers in Overseas Markets
BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  In particular, BIO informed the United States Trade Representative (USTR) of the persistent problems BIO member companies face abroad including global…

It Starts with One—Partnering Meeting Leads to Unique Public-Private Partnership
Biotechnology: A Critical Tool in Achieving the UN Sustainable Development Goals
Recyclable plastic bottles, mustard seed jet fuel, Insulin and Golden Rice. These are just a few biotechnology products that are contributing to the achievement of the UN Sustainable Development Goals (UN SDGs). A collection of 17 goals and 169 targets set by the UN General Assembly in 2015, the…

Hand holding newspaper that reads GET READY FOR BREXIT
How Will Brexit Impact Patients and Biotech Innovation?
The clock is beginning to run out for British Parliament to finalize a Brexit plan. As things stand, the UK is due to leave the European Union on March 29th regardless of whether there is an approved agreement not. A European court has ruled that the UK can halt the process and stay in the EU at…

Abstract DNA in red and gold hues
Making Innovative Drugs Available Globally
In order to bring innovative biopharmaceutical to the global market companies must navigate the unique regulations of each country they seek to enter. This enormous regulatory hurdle delays access to the newest innovations and is a primary reason patients in the U.S. often have access to life…

China flag pinned to China on a map
USDA Report: China’s Biotech Crop Approval Process Becoming More Unpredictable and Burdensome
Across the United States, farmers use biotech crops to address production challenges – such as pests, disease, and extreme weather – and improve the productivity and health of their plants. However, American farmers planting such crops are often unable to access the Chinese market and export…

BIO Comments on Objectives for U.S. Japan Trade Agreement
BIO supports the U.S. Trade Representative’s (USTR) negotiations with the Government of Japan as an opportunity to grow U.S. exports and create U.S. jobs. We would strongly urge the U.S. government to build on the recent U.S.-Mexico-Canada agreement and that the agreement comprehensively addresses…

BIO Hosts Embassy Briefing on International Economic Development
Last week BIO hosted embassy representatives from over 25 countries to debut a new report that highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world. The 5th edition of the Building…

It Starts with One—Presentation at BIO 2018 Leads to International Agreement
A recently announced agreement between the New Jersey Economic Development Authority and the Israel Innovation Authority is a fitting testament to the theme for the upcoming BIO 2019 International Convention: It Starts with One.  In the intensely innovative biotechnology space, one meeting; one…

UN Proposals to Weaken IP Will Not Benefit Patients
Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in New York City. Among the many high-level meetings taking place, the UN will be evaluating progress of sustainable development goal (UN SDG) #3, “Ensuring Access to Healthcare,” with a specific focus on…

#MakeHistory: Highlighting History I China
Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel the US pharmaceutical startup sector. With over $1.4 billion invested by Chinese VC funds into private US biotechnology firms in Q1 2018 alone, the Chinese investment community represents a…